Alto Neuroscience (ANRO) Times Interest Earned (2023 - 2026)
Alto Neuroscience (ANRO) reported Times Interest Earned of -$49.79 for Q1 2026, down 535.3% on a YoY basis from $11.44 in Q1 2025, and down 24.08% sequentially from -$40.13 in Q4 2025.
Alto Neuroscience (ANRO) Times Interest Earned (2023 - 2026) Analysis & Trends
Alto Neuroscience (ANRO) has 4 years of Times Interest Earned data on file, last reported at -$49.79 in Q1 2026.
- For the quarter ending Q1 2026, Times Interest Earned fell 535.3% year-over-year to -$49.79; the trailing twelve-month figure through Mar 2026 stood at -$47.11 (down 34.79% YoY), and the FY2025 full-year result was -$1.27, up 30.62% from the prior year.
- Times Interest Earned slipped to -$49.79 in Q1 2026, from -$40.13 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $115.34 in Q4 2023 to a low of -$54.11 in Q3 2024.
- A 4-year average of -$18.8 and a median of -$24.3 in 2023 frame the typical range for Times Interest Earned.
- Across the five-year window, Times Interest Earned surged 99.98% in 2025 and sank 535.3% in 2026, its largest moves.
- Tracing ANRO's Times Interest Earned over 4 years: stood at $115.34 in 2023, then tumbled by 144.25% to -$51.04 in 2024, then climbed by 21.38% to -$40.13 in 2025, then fell by 24.08% to -$49.79 in 2026.
- Business Quant data shows ANRO's Times Interest Earned at -$49.79 in Q1 2026, -$40.13 in Q4 2025, and -$0.01 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -0.38 |
| 10 | Alto Neuroscience | 869.36 Mn | 869.36 Mn | - | -49.79 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -49.79 |
| Dec 31, 2025 | -40.13 |
| Sep 30, 2025 | -0.01 |
| Jun 30, 2025 | -0.05 |
| Mar 31, 2025 | -7.84 |
| Dec 31, 2024 | -51.04 |
| Sep 30, 2024 | -54.11 |
| Jun 30, 2024 | -45.85 |
| Mar 31, 2024 | -41.58 |
| Dec 31, 2023 | 115.34 |
| Sep 30, 2023 | -24.30 |
| Jun 30, 2023 | -22.81 |
| Mar 31, 2023 | -22.23 |